Cannabinoid receptor ligands

US7071213B2 · kind B2 · utility

Assignee

• SCHERING CORPORATION · US

Inventors

• Richard J. Friary · Florence, US
• Joseph A. Kozlowski · Princeton, US
• Bandarpalle B. Shankar · Readington, US
• Michael K. C. Wong · New Brunswick, US
• Guowei Zhou · Somerville, US
• Brian J. Lavey · New Providence, US
• Neng-Yang Shih · Lexington, US
• Ling Tong · Hackettstown, US
• Lei Chen · Singapore, SG
• Youheng Shu · Blue Bell, US

Key dates

• Filing date: Nov 12, 2002
• Grant date: Jul 4, 2006
• Expiry date: May 11, 2023

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D413/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

There are disclosed compounds of the formula I: or a pharmaceutically acceptable salt of the compound, which exhibit anti-inflammatory and immunomodulatory activity. Also disclosed are pharmaceutical compositions containing said compounds.